General practice is repeatedly described as the front door of the NHS. It\u2019s where continuity lives, where prevention either happens or doesn\u2019t, and where workforce gaps show up as appointment delays and clinician burnout.<\/p>\n
That\u2019s why one statistic in the GMC\u2019s Workforce report 2025 should be treated as a strategic planning fact, not a cultural talking point:<\/p>\n
In 2024, half (50%) of first-year GP specialty trainees (ST1) qualified outside the UK.<\/p>\n
If you\u2019re serious about \u201cprioritising UK graduates\u201d in postgraduate training (as the report notes is the stated direction in England), GP is where the policy becomes real, fast. Not in abstract. Not in rhetoric. In the number of trainees starting on day one.<\/p>\n
This blog sets out what the report actually shows about GP\u2019s training pipeline, why it matters, what it does not prove, and how to design policy that doesn\u2019t destabilise a service that already operates at the edge.<\/p>\n
<\/p>\n
The report provides multiple lenses on training:<\/p>\n
Across specialty training overall, the headline is stark: the success rate for UK graduates remains much higher than for non\u2011UK graduates. In 2024 the report highlights 69% vs 23% (UK vs non\u2011UK) for getting an offer for CT1\/ST1 posts.<\/p>\n
But GP is not \u201cjust another programme.\u201d At programme level:<\/p>\n
That combination, high UK offer rate, but large non\u2011UK intake is important. It suggests GP is not a programme where UK graduates are being \u201cblocked.\u201d Instead, it suggests something else is happening:<\/p>\n
In other words: GP is where workforce need and training pathway demand meet and where international recruitment has become structurally embedded.<\/p>\n
<\/p>\n
The report adds another perspective using competition ratios (applications per available post) and non\u2011UK proportions in CT1\/ST1.<\/p>\n
It notes that general practice has a relatively low competition ratio and is not unique in having low competition ratios alongside relatively high non\u2011UK proportions, other examples include histopathology, internal medicine, and core psychiatry.<\/p>\n
This matters because it reframes the debate from \u201cwho deserves training\u201d to \u201cwhat the system is incentivising and attracting.\u201d<\/p>\n
A programme with lower competition ratios may still be clinically demanding and strategically critical, but it may be less sought after by UK graduates for reasons outside this report\u2019s scope (working conditions, perceptions, geography, portfolio fit, lifestyle, long-term career expectations). The report doesn\u2019t diagnose those drivers. It simply shows the outcome pattern: non\u2011UK doctors are applying into programmes UK graduates are less likely to apply for.<\/p>\n
That point is central to why a blunt \u201cprioritisation\u201d approach can backfire. If UK graduates aren\u2019t applying in sufficient numbers today, you cannot \u201cprioritise\u201d your way to a full GP intake without either:<\/p>\n
<\/p>\n
The report spells out a key mechanism under discussion: thresholds requiring NHS experience (eg, \u201ctwo years in the NHS before training eligibility\u201d) as one way of reducing non\u2011UK doctors in training.<\/p>\n
Here\u2019s the crucial detail: among non\u2011UK PMQ doctors in training in 2024:<\/p>\n
The report is clear about the implication: any UK-experience threshold will change the pool of doctors eligible to apply, and could disrupt training pipelines in the short term, especially in programmes with historically higher non\u2011UK proportions such as general practice and psychiatry.<\/p>\n
This is not an argument for \u201cno change.\u201d It is an argument for sequencing and safeguards.<\/p>\n
Because GP is:<\/p>\n
If you disrupt the supply of ST1 trainees without a replacement plan, you won\u2019t feel it in a spreadsheet, you\u2019ll feel it in patient access.<\/p>\n
<\/p>\n
One of the report\u2019s most important \u201cquiet\u201d messages is methodological: it reports headcount, not full-time equivalent (FTE). And it notes that in primary care, FTE-to-headcount ratios have been falling over time, for example, England\u2019s GP FTE-to-headcount ratio fell from 0.81 (Dec 2015) to 0.73 (Dec 2024).<\/p>\n
This matters for GP more than almost any other specialty because:<\/p>\n
So the GP workforce conversation can\u2019t be reduced to who enters training; it must also include what kind of working patterns the system is structurally creating.<\/p>\n
<\/p>\n
It\u2019s tempting to turn \u201c50% non\u2011UK ST1\u201d into a political talking point. But the report\u2019s data does not support simplistic narratives like:<\/p>\n
The report instead supports a more practical interpretation: GP is absorbing international doctors because it needs to and because the system\u2019s applicant preferences and workforce pressures create that outcome.<\/p>\n
<\/p>\n
The report pushes decision-makers toward evidence-led design. It doesn\u2019t tell you which policy to choose, but it makes certain requirements unavoidable:<\/p>\n
1) Protect GP intake volume during any transition<\/p>\n
If eligibility rules change, you need mechanisms to avoid a sudden drop in GP ST1 starts, especially given how quickly pipeline changes affect service capacity.<\/p>\n
2) Make GP more attractive to UK graduates in real terms<\/p>\n
Prioritisation can only reorder demand that already exists. If demand isn\u2019t there, you need to build it through job design, flexible training pathways, supervision quality, and credible progression.<\/p>\n
3) Keep the UK a credible destination for global talent<\/p>\n
The report\u2019s foreword warns that doctors are mobile, and perceived lack of progression can push talent elsewhere. GP is one of the clearest examples: if UK training becomes implausible for non\u2011UK doctors, the UK may lose a major motivator for migration and GP posts may become harder to fill, not easier.<\/p>\n
<\/p>\n
General practice is where workforce policy meets patient access.<\/p>\n
The report shows GP\u2019s training pipeline is already deeply intertwined with international doctors, not because of \u201cpreference\u201d in selection, but because the overall workforce system (applications, offers, and programme demand) is producing that composition.<\/p>\n
If leaders want to change that, they can, but they\u2019ll need a careful, evidence-led transition plan that protects intake volume, improves GP\u2019s attractiveness to UK graduates, and avoids undermining the UK\u2019s ability to recruit and retain global talent.<\/p>\n
In GP, workforce disruption doesn\u2019t stay on paper. It turns into waiting times.<\/p>\n
Source: GMC Workforce Report 2025<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":" General practice is repeatedly described as the front door of the NHS. It\u2019s where continuity lives, where prevention either happens or doesn\u2019t, and where workforce gaps show up as appointment delays and clinician burnout. That\u2019s why one statistic in the GMC\u2019s Workforce report 2025 should be treated as a strategic planning fact, not a cultural…<\/p>\n","protected":false},"author":26,"featured_media":61250,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","footnotes":""},"categories":[25],"tags":[],"class_list":["post-61246","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-leadership"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/comments?post=61246"}],"version-history":[{"count":1,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61246\/revisions"}],"predecessor-version":[{"id":61251,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61246\/revisions\/61251"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/media\/61250"}],"wp:attachment":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/media?parent=61246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/categories?post=61246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/tags?post=61246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}